Brokers name 3 ASX shares to buy today

Brokers are bullish on these ASX shares…

| More on:
ASX shares Business man marking buy on board and underlining it

Image Source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It has been another busy week for Australia’s top brokers. This has led to the release of a large number of broker notes.

Three broker buy ratings that you might want to know more about are summarised below. Here’s why brokers think these ASX shares are in the buy zone:

AVITA Medical Inc (ASX: AVH)

According to a note out of Bell Potter, its analysts have retained their buy rating and $9.80 price target on this regenerative medicine company’s shares. This follows news that the US Centre for Medicare has approved a new reimbursement code that will provide separate payment for AVITA’s Recell devices used in the outpatient setting. Bell Potter feels this represents an important breakthrough for the company and further validation of the clinical benefit of the Recell technology. It notes that this new code is only granted to devices that offer a substantial clinical improvement over the standard of care. The AVITA share price is trading at $5.12 today.

Hipages Group Holdings Ltd (ASX: HPG)

A note out of Goldman Sachs reveals that its analysts have retained their buy rating and lifted their price target on this tradie platform provider’s shares to $4.90. This follows news that the company has acquired a 25% interest in property management technology platform, Bricks + Agent. Goldman notes that this gives Hipages exposure to the A$21 billion Residential and Commercial Property Management channel. Goldman also expects the investment to expand Hipages’ ability to capture a greater share of tradie spend. The Hipages share price is fetching $4.02 on Friday.

Suncorp Group Ltd (ASX: SUN)

Analysts at Citi have upgraded this banking and insurance giant’s shares to a buy rating with a $12.80 price target. The broker notes that Suncorp’s hazards claims have overrun in FY 2022. This has led to the broker downgrading its earnings estimates for the current financial year. However, Citi remains positive in the medium term and believes recent share price weakness has left its shares trading at an attractive level. The Suncorp share price is trading at $11.51 this afternoon.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended Avita Medical Limited and Hipages Group Holdings Ltd. The Motley Fool Australia has recommended Avita Medical Limited and Hipages Group Holdings Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

A woman sits crossed leg on seats at an airport holding her ticket and smiling.
Travel Shares

Own Flight Centre shares? Here’s what to expect from its FY22 results

Here's what to expect from Flight Centre's FY 2022 results...

Read more »

A man leans forward over his phone in his hands with a satisfied smirk on his face although he has just learned something pleasing or received some satisfying news.
Blue Chip Shares

Brokers say BHP and this ASX 200 share are buys

Here are two ASX 200 shares rated as buys....

Read more »

A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate
Broker Notes

Goldman Sachs tips huge returns for the Goodman share price

Goldman Sachs says Goodman's shares could rise materially..

Read more »

A male broker wearing a dark blue suit and tie puts his finger to his lips to signal a secret tip about the Xero share price
Resources Shares

‘Clearly under the radar’: Expert reveals hidden gem ASX share he’s holding

One fund manager lets slip a stock about to go crazy that no one else knows about.

Read more »

Broker Notes

Why these 2 ASX shares rocketed 40% last month

The rise in value of these stocks was no fluke, as one expert is holding onto them for further gains.

Read more »

A woman looks in anticipation at her laptop, watching eagerly.
Technology Shares

The Appen share price is down 20% in a month. Is it going lower?

Will Appen's shares continue to slide?

Read more »

Young woman using computer laptop with hand on chin thinking about question, pensive expression.
Broker Notes

Is the Beach Energy share price a buy following its post-reporting sell-off?

Are brokers still optimistic after slamming the company's earnings and guidance? We take a look.

Read more »

A man in his office leans back in his chair with his hands behind his head looking out his window at the city, sitting back and relaxed, confident in his ASX share investments for the long term.
Broker Notes

Why this broker sees plenty of upside for the ResMed share price

ResMed shares could be in the buy zone...

Read more »